SCFAs, serving as an energy source for colonic epithelial cells, could influence the expression of tight junction proteins, enhance intestinal barrier function, activate the AMPK/mTOR pathway, and modulate the immune system, thereby alleviating inflammation state and improving metabolic disorders in diabetic mice. The gene discussed is MTOR; the disease is metabolic disease.